Header Logo

Connection

CHARLES WYKOFF to Retinal Diseases

Back to Details
This is a "connection" page, showing publications CHARLES WYKOFF has written about Retinal Diseases.
CHARLES WYKOFF
Connection Strength
5.025
Retinal Diseases
  1. Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII). BMJ Open Ophthalmol. 2022 12; 7(1).
    View in: PubMed
    Score: 0.661
  2. Retinal non-perfusion in diabetic retinopathy. Eye (Lond). 2022 02; 36(2):249-256.
    View in: PubMed
    Score: 0.619
  3. Noncompliance in Prospective Retina Clinical Trials: Analysis of Factors Predicting Loss to Follow-up. Am J Ophthalmol. 2020 02; 210:86-96.
    View in: PubMed
    Score: 0.531
  4. Suprachoroidally injected pharmacological agents for the treatment of chorio-retinal diseases: a targeted approach. Acta Ophthalmol. 2019 Aug; 97(5):460-472.
    View in: PubMed
    Score: 0.505
  5. Relationship Between Visual Acuity and Retinal Thickness During Anti-Vascular Endothelial Growth Factor Therapy for Retinal Diseases. Am J Ophthalmol. 2017 Aug; 180:8-17.
    View in: PubMed
    Score: 0.449
  6. Anti-vascular endothelial growth factor agents for pediatric retinal diseases. Int Ophthalmol Clin. 2011; 51(1):185-99.
    View in: PubMed
    Score: 0.288
  7. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR STAGES 3 AND 4 PROLIFERATIVE SICKLE CELL RETINOPATHY RESULTS IN IMPROVED ANATOMICAL AND VISUAL OUTCOMES. Retina. 2026 Jan 01; 46(1):171-178.
    View in: PubMed
    Score: 0.204
  8. Emerging clinical evidence of a dual role for Ang-2 and VEGF-A blockade with faricimab in retinal diseases. Graefes Arch Clin Exp Ophthalmol. 2025 May; 263(5):1239-1247.
    View in: PubMed
    Score: 0.190
  9. Anti-VEGF Pharmaceutical Prior Authorization in Retina Practices. JAMA Ophthalmol. 2024 Aug 01; 142(8):716-721.
    View in: PubMed
    Score: 0.185
  10. SUPRACHOROIDAL SPACE INJECTION TECHNIQUE: Expert Panel Guidance. Retina. 2024 06 01; 44(6):939-949.
    View in: PubMed
    Score: 0.183
  11. Retinal non-perfusion: recognizing and defining what is important. Eye (Lond). 2024 Jun; 38(9):1608-1609.
    View in: PubMed
    Score: 0.180
  12. Refill-Exchange Procedure of the Port Delivery System With Ranibizumab: Overview and Clinical Trial Experience. Ophthalmic Surg Lasers Imaging Retina. 2022 05; 53(5):257-265.
    View in: PubMed
    Score: 0.158
  13. Deep learning-enabled ultra-widefield retinal vessel segmentation with an automated quality-optimized angiographic phase selection tool. Eye (Lond). 2022 09; 36(9):1783-1788.
    View in: PubMed
    Score: 0.150
  14. Expanded Clinical Spectrum of Pentosan Polysulfate Maculopathy: A Macula Society Collaborative Study. Ophthalmol Retina. 2022 03; 6(3):219-227.
    View in: PubMed
    Score: 0.150
  15. THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES: A Review. Retina. 2021 01 01; 41(1):1-19.
    View in: PubMed
    Score: 0.144
  16. Clinical Characterization of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders. Transl Vis Sci Technol. 2020 10; 9(11):27.
    View in: PubMed
    Score: 0.142
  17. Real-World Trends in Intravitreal Injection Practices among American Retina Specialists. Ophthalmol Retina. 2019 08; 3(8):656-662.
    View in: PubMed
    Score: 0.128
  18. Precise montaging and metric quantification of retinal surface area from ultra-widefield fundus photography and fluorescein angiography. Ophthalmic Surg Lasers Imaging Retina. 2014 Jul-Aug; 45(4):312-7.
    View in: PubMed
    Score: 0.092
  19. Comment on "fundus autofluorescence and multiple evanescent white dot syndrome". Retina. 2009 Oct; 29(9):1377-8; author reply 1378-9.
    View in: PubMed
    Score: 0.066
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.